Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
66 participants
OBSERVATIONAL
2022-11-15
2024-06-10
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The precise description of the consequences of these functional impairments and their impact on quality of life after SE requiring intensive care management has been little studied.
Indeed, if cognitive, physical and mental impairments are now identified in the populations of patients who required intensive care under the term post-resuscitation syndrome (PICS), neuronal lesions consecutive to the SE itself or to its cause could be responsible for these different functional alterations. Thus, the following have been described: (i) cognitive disorders in the areas of attention, executive functions and verbal fluency, visual and working memory disorders, but also spatio-temporal disorders; (ii) physical disorders such as the so-called post-resuscitation polyneuromyopathy; and (iii) mental disorders such as anxiety disorders, depressive states or those related to post-traumatic stress.
Assessment and characterization of patient-reported outcomes is essential to complement the holistic assessment of clinically relevant outcomes from the patient's perspective. Here, we propose the development of a cross-sectional collection of PROs of the different constituents of PICs and HR-QOLs, and associated with functional patient outcomes, in those who required ICU management for status epilepticus.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Patient-reported Outcome and Patient-reported Experience After Status Epilepticus
NCT06100978
Status Epilepticus in the Critically Ill Patients
NCT03457831
Epileptic Seizures in Intensive Care Units
NCT03860467
Epidemiology and Prognosis of Encephalitis in Intensive Care
NCT02906631
Risk Factors of SUDEP
NCT03074279
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Patients previously included in the ICTAL registry (Status Epilepticus cohort NCT03457831)
* Survivors after ICU management for Status Epilepticus More than 3 months and less than 5 years after ICU discharge
Exclusion Criteria
* Opposition to participate
* Unread and unwritten French language
* Patient not affiliated to a Social Security system
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Versailles Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Jacq Gwenaelle
Investigator Coordinator
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Gwenaelle JACQ, RN,MSc,PhDc
Role: PRINCIPAL_INVESTIGATOR
Versailles Hospital
Stephane LEGRIEL, MD,PhD
Role: STUDY_DIRECTOR
Versailles Hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
CHVersailles
Le Chesnay, Yvelines, France
CH de Bethune
Beuvry, , France
CHU de Brest
Brest, , France
CH de Brive la Gaillarde
Brive-la-Gaillarde, , France
CH de Cannes
Cannes, , France
CH du Cotentin
Cherbourg, , France
CHU de Beaujon
Clichy, , France
CHU Henri Mondor
Créteil, , France
CHU de Dijon
Dijon, , France
CH de la Rochelle
La Rochelle, , France
GH Sud Ile de France
Melun, , France
CHU de Nantes
Nantes, , France
GH Paris Saint Joseph
Paris, , France
Hôpital Claude Galien
Quincy-sous-Sénart, , France
CH de Roanne
Roanne, , France
CH de Toulon-La Seyne sur Mer
Toulon, , France
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
P21/11 - POSEIDON
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.